Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-29

Clinical Trial Update: Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating pregabalin for prevention of chemotherapy-induced nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Faculdade de Medicina do ABC | Conditions: Nausea | Phase 2 | Status: UNKNOWN